"No swift action" on US CBD regulation after FDA comments, warns analyst

Home › "No swift action" on US CBD regulation after FDA comments, warns analyst

CBD beverage producers in the US may have to wait for clarity on regulation as authorities look set to miss a February deadline, an analyst has said.

16.02	'Mutual interest' in UK avoiding US steel tariffs, Reynolds says
15.02	Weekly Recap: AkzoNobel, BASF, Pigments Top This Weeks Stories
14.02	Why don't Europeans buy more American cars?
14.02	Samsung Gear S Enhances the Smart Wearable Experience
14.02	Apple Investigating Reports of iCloud Vulnerabilities
14.02	Galaxy Note 4
14.02	HTC Desire 820 announced
14.02	Motorola Launches Smartphones, Wearables and Accessories
More »

je.st